Cardiac Biomarkers Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
8523 | Date :
Jan, 2023 | Pages :
182 | Region : Global |
Publisher : 99 Strategy
Cardiovascular diseases are leading cause of morbidity and mortality globally. Biomarkers are generally used as an indicator forparticular diseases such as rheumatic and congenital heart diseases and cardiac arrhythmia. Cardiac biomarkers are measurable and quantifiable biological parameters. These are specifically used to check the presence or severity of cardiovascular diseases. Cardiac biomarkers are the substances that are released into blood when heart is damaged. These biomarkers are also used for diagnosing and monitoring diseases such as coronary syndrome or cardiac ischemia. The symptoms of these diseases includes chest pain, shortness of breath and nausea that ultimately leads to heart attack or angina. Cardiac biomarker tests helps to detect presence of coronary syndrome and cardiac ischemia to evaluate its severity and diagnosis.
The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment. Cardiac biomarkers are protein-based traceable substances used as an indicator of biologic state and used for diagnostic and prognostic purposes associated with heart. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiac biomarkers market has witnessed a greater demand over the past five to six years.
There is a high demand for cardiac biomarkers due to their proficiency and the ability to provide accurate results. The number of clinical trials conducted for cardiac biomarkers is steadily increasing since manufactures, universities, and research institutes are focused on improving the efficiency and efficacy of the biomarkers. Cardiac biomarker manufacturers are increasingly focusing on R&D to perform several clinical trials to prove the effectiveness of the products and increase their consumer base. According to our industry research and analysis, the increase in number of clinical trials will be one of the key trends that will gain traction in the cardiac biomarkers market during the next few years.
North America leads the global market, owing to the high demand for cardiac testing, high CVD prevalence rate and growing awareness towards cardiac diagnostics solutions. Asia-Pacific is growing at the fastest CAGR due to the modernization, increasing disposable incomes and rising affordability for the advanced cardiac treatments.
The Global Cardiac Biomarkers Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Cardiac Biomarkers Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Abbott
Alere
F. Hoffmann-La Roche
Advanced ImmunoChemical
AgPlus Diagnostics
BG Medicine
BioLegend
bioMérieux
Bio-Rad Laboratories
BODITECH MED
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Troponin
CK-MB
Natriuretic Peptides - BNP and NT-proBNP
Myoglobin
Others
In Market segmentation by applications :
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Cardiac Biomarkers Market for the forecast period 2023-2030?
• What are the driving forces in the Cardiac Biomarkers Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Cardiac Biomarkers industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cardiac Biomarkers Market Size Growth Rate by Type (2020-2030)
1.3.2 Troponin
1.3.3 CK-MB
1.3.4 Natriuretic Peptides - BNP and NT-proBNP
1.3.5 Myoglobin
1.3.6 Others
1.4 Market Segment by Application
1.4.1 Global Cardiac Biomarkers Market Share by Application (2020-2030)
1.4.2 Acute Coronary Syndrome
1.4.3 Myocardial Infarction
1.4.4 Congestive Heart Failure
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Cardiac Biomarkers Production Value 2015-2030
2.1.2 Global Cardiac Biomarkers Production 2015-2030
2.1.3 Global Cardiac Biomarkers Capacity 2015-2030
2.1.4 Global Cardiac Biomarkers Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2020-2030
2.2.1 Global Cardiac Biomarkers Market Size CAGR of Key Regions
2.2.2 Global Cardiac Biomarkers Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Cardiac Biomarkers Capacity by Manufacturers
3.1.2 Global Cardiac Biomarkers Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Cardiac Biomarkers Revenue by Manufacturers (2018 - 2022)
3.2.2 Cardiac Biomarkers Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Cardiac Biomarkers Market Concentration Ratio (CR5 and HHI)
3.3 Cardiac Biomarkers Price by Manufacturers
3.4 Key Manufacturers Cardiac Biomarkers Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cardiac Biomarkers Market
3.6 Key Manufacturers Cardiac Biomarkers Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Troponin Production and Production Value (2018 - 2022)
4.1.2 CK-MB Production and Production Value (2018 - 2022)
4.1.3 Natriuretic Peptides - BNP and NT-proBNP Production and Production Value (2018 - 2022)
4.1.4 Myoglobin Production and Production Value (2018 - 2022)
4.1.5 Others Production and Production Value (2018 - 2022)
4.2 Global Cardiac Biomarkers Production Market Share by Type
4.3 Global Cardiac Biomarkers Production Value Market Share by Type
4.4 Cardiac Biomarkers Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Cardiac Biomarkers Consumption by Application
6 Production by Regions
6.1 Global Cardiac Biomarkers Production (History Data) by Regions 2018 - 2022
6.2 Global Cardiac Biomarkers Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Cardiac Biomarkers Production Growth Rate 2018 - 2022
6.3.2 United States Cardiac Biomarkers Production Value Growth Rate 2018 - 2022
6.3.3 Key Players in United States
6.3.4 United States Cardiac Biomarkers Import & Export
6.4 European Union
6.4.1 European Union Cardiac Biomarkers Production Growth Rate 2018 - 2022
6.4.2 European Union Cardiac Biomarkers Production Value Growth Rate 2018 - 2022
6.4.3 Key Players in European Union
6.4.4 European Union Cardiac Biomarkers Import & Export
6.5 China
6.5.1 China Cardiac Biomarkers Production Growth Rate 2018 - 2022
6.5.2 China Cardiac Biomarkers Production Value Growth Rate 2018 - 2022
6.5.3 Key Players in China
6.5.4 China Cardiac Biomarkers Import & Export
6.6 Rest of World
6.6.1 Japan
6.6.2 Korea
6.6.3 India
6.6.4 Southeast Asia
7 Cardiac Biomarkers Consumption by Regions
7.1 Global Cardiac Biomarkers Consumption (History Data) by Regions
7.2 United States
7.2.1 United States Cardiac Biomarkers Consumption by Type
7.2.2 United States Cardiac Biomarkers Consumption by Application
7.3 European Union
7.3.1 European Union Cardiac Biomarkers Consumption by Type
7.3.2 European Union Cardiac Biomarkers Consumption by Application
7.4 China
7.4.1 China Cardiac Biomarkers Consumption by Type
7.4.2 China Cardiac Biomarkers Consumption by Application
7.5 Rest of World
7.5.1 Rest of World Cardiac Biomarkers Consumption by Type
7.5.2 Rest of World Cardiac Biomarkers Consumption by Application
7.5.1 Japan
7.5.2 Korea
7.5.3 India
7.5.4 Southeast Asia
8 Company Profiles
8.1 Abbott
8.1.1 Abbott Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Cardiac Biomarkers
8.1.4 Cardiac Biomarkers Product Introduction
8.1.5 Abbott Recent Development
8.2 Alere
8.2.1 Alere Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Cardiac Biomarkers
8.2.4 Cardiac Biomarkers Product Introduction
8.2.5 Alere Recent Development
8.3 F. Hoffmann-La Roche
8.3.1 F. Hoffmann-La Roche Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Cardiac Biomarkers
8.3.4 Cardiac Biomarkers Product Introduction
8.3.5 F. Hoffmann-La Roche Recent Development
8.4 Advanced ImmunoChemical
8.4.1 Advanced ImmunoChemical Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Cardiac Biomarkers
8.4.4 Cardiac Biomarkers Product Introduction
8.4.5 Advanced ImmunoChemical Recent Development
8.5 AgPlus Diagnostics
8.5.1 AgPlus Diagnostics Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Cardiac Biomarkers
8.5.4 Cardiac Biomarkers Product Introduction
8.5.5 AgPlus Diagnostics Recent Development
8.6 BG Medicine
8.6.1 BG Medicine Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Cardiac Biomarkers
8.6.4 Cardiac Biomarkers Product Introduction
8.6.5 BG Medicine Recent Development
8.7 BioLegend
8.7.1 BioLegend Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Cardiac Biomarkers
8.7.4 Cardiac Biomarkers Product Introduction
8.7.5 BioLegend Recent Development
8.8 bioMérieux
8.8.1 bioMérieux Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Cardiac Biomarkers
8.8.4 Cardiac Biomarkers Product Introduction
8.8.5 bioMérieux Recent Development
8.9 Bio-Rad Laboratories
8.9.1 Bio-Rad Laboratories Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Cardiac Biomarkers
8.9.4 Cardiac Biomarkers Product Introduction
8.9.5 Bio-Rad Laboratories Recent Development
8.10 BODITECH MED
8.10.1 BODITECH MED Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Cardiac Biomarkers
8.10.4 Cardiac Biomarkers Product Introduction
8.10.5 BODITECH MED Recent Development
9 Market Forecast
9.1 Global Market Size Forecast
9.1.1 Global Cardiac Biomarkers Capacity, Production Forecast 2020-2030
9.1.2 Global Cardiac Biomarkers Production Value Forecast 2020-2030
9.2 Market Forecast by Regions
9.2.1 Global Cardiac Biomarkers Production and Value Forecast by Regions 2020-2030
9.2.2 Global Cardiac Biomarkers Consumption Forecast by Regions 2020-2030
9.3 United States
9.3.1 Production and Value Forecast in United States
9.3.2 Consumption Forecast in United States
9.4 European Union
9.4.1 Production and Value Forecast in European Union
9.4.2 Consumption Forecast in European Union
9.5 China
9.5.1 Production and Value Forecast in China
9.5.2 Consumption Forecast in China
9.6 Rest of World
9.6.1 Japan
9.6.2 Korea
9.6.3 India
9.6.4 Southeast Asia
9.7 Forecast by Type
9.7.1 Global Cardiac Biomarkers Production Forecast by Type
9.7.2 Global Cardiac Biomarkers Production Value Forecast by Type
9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
10.1 Value Chain Analysis
10.2 Sales Channels Analysis
10.2.1 Cardiac Biomarkers Sales Channels
10.2.2 Cardiac Biomarkers Distributors
10.3 Cardiac Biomarkers Customers
11 Opportunities & Challenges, Threat and Affecting Factors
11.1 Market Opportunities
11.2 Market Challenges
11.3 Porters Five Forces Analysis
12 Key Findings
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.